Colon Screening Market Opportunities in Molecular Diagnostic Advances

The global colon screening market size was valued at USD 17.21 billion in 2024 and is projected to reach USD 22.21 billion by 2030, expanding at a CAGR of 4.4% from 2025 to 2030. Market growth is driven by the rising prevalence of colorectal cancer, increasing government initiatives to promote cancer screening, and continuous technological advancements.

For example, in December 2023, Medtronic expanded its artificial intelligence partnership with Cosmo Pharmaceuticals, the developer of plug-in software designed to automatically detect health concerns during endoscopic procedures.

The increasing incidence of colorectal diseases remains a primary growth driver for the colon screening industry. Colorectal cancer, one of the most serious gastrointestinal conditions, is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Its rising occurrence underscores the urgent need for early detection and effective screening solutions. According to the World Cancer Research Fund, around 1.93 million new colorectal cancer cases were reported globally in 2022, making it one of the most widespread malignancies. Furthermore, the World Health Organization highlights that regions such as Europe, Australia, and New Zealand report the highest incidence rates, largely due to lifestyle factors, dietary habits, and aging demographics.

Governments worldwide are prioritizing colon cancer screening as part of public health initiatives to reduce cancer-related mortality. Many countries have launched awareness and prevention programs that focus on early detection, accessibility, and affordability, encouraging individuals to undergo regular screenings.

Key Market Highlights:

• North America dominated the global colon screening market with a 51.3% revenue share in 2024.
• The U.S. led the North America market in 2024.
• By type, the test segment accounted for the largest share at 78.7% in 2024.
• By end-use, the hospitals management segment held a dominant share of 49.9% in 2024.

Download a free sample PDF of the Colon Screening Market Intelligence Study from Grand View Research.

Market Performance:

• 2024 Market Size: USD 17.21 Billion
• 2030 Projected Market Size: USD 22.21 Billion
• CAGR (2025–2030): 4.4%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Prominent Companies & Market Dynamics:

Leading players in the colon screening industry are adopting strategies such as product portfolio expansion, partnerships, mergers & acquisitions, and geographic expansion to strengthen their market presence.

Key Companies:

• Olympus Corporation
• PENTAX Medical (Hoya Corporation)
• FUJIFILM Holdings Corporation
• Medtronic
• Ambu A/S
• Baxter (Hillrom & Welch Allyn)
• EndoFresh
• Daichuan Medical
• Bracco
• Varay Laborix

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.

Conclusion

The global colon screening market is set for steady growth, fueled by the increasing incidence of colorectal cancer, supportive government initiatives, and technological progress in diagnostic tools. With North America leading the market and Asia Pacific emerging as the fastest-growing region, opportunities for expansion are significant. Industry leaders are focusing on AI-driven innovations, partnerships, and portfolio diversification to enhance early detection and improve patient outcomes. As awareness of preventive healthcare continues to rise, colon screening is expected to play a critical role in reducing cancer-related mortality and driving market growth through 2030.